CSCheikh I. Seye

Cheikh I. Seye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cheikh I. Seye has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Shaomin Qian

    Department of Cellular & Integrative Physiology, Indiana University School of Medicine 635 Barnhill Drive MS 332, Indianapolis, IN 46202

    4 shared publications
  • April Hoggatt

    Department of Cellular & Integrative Physiology, Indiana University School of Medicine 635 Barnhill Drive MS 332, Indianapolis, IN 46202

    3 shared publications
  • Paul B. Herring

    Department of Cellular & Integrative Physiology, Indiana University School of Medicine 635 Barnhill Drive MS 332, Indianapolis, IN 46202

    2 shared publications
  • Alexander G. Obukhov

    Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine

    1 shared publication
  • Cansu Agca

    College of Veterinary Medicine Department of Veterinary Pathobiology, University of Missouri, USA

    1 shared publication
  • Carl F. Ware

    Sanford-Burnham Medical Institute, La Jolla, CA 92037, United States

    1 shared publication

Latest Publications

  • Endothelial Cell–Specific Deletion of P2Y 2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice

    by Xingjuan Chen, Shaomin Qian, April Hoggatt, Hongying Tang, Timothy A. Hacker, Alexander G. Obukhov, Paul B. Herring, Cheikh I. Seye

    Objective—: Nucleotide P2Y 2 receptor (P2Y 2 R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y 2 R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE −/− ) mice. Because P2Y 2 R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y 2 R in the pathogenesis of atherosclerosis. Approach and Results—: EC-specific P2Y 2 R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y 2 R floxed mice. Endothelial P2Y 2 R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y 2 R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y 2 R in the development of atherosclerotic lesions by crossing the EC-specific P2Y 2 R knockout mice onto an ApoE −/− background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y 2 R-deficient ApoE −/− mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y 2 R-deficient ApoE −/− mice. Furthermore, EC-specific P2Y 2 R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants. Conclusions—: EC-specific P2Y 2 R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE −/− mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.


  • Open Access

    The P2Y 2 nucleotide receptor is an inhibitor of vascular calcification

    by Shaomin Qian, Jenna N. Regan, Maxwell T. Shelton, April Hoggatt, Khalid S. Mohammad, Paul B. Herring, Cheikh I. Seye


  • Open Access

    Direct Evidence for P2Y2 Receptor Involvement in Vascular Response to Injury

    by Yuksel Agca, Shaomin Qian, Cansu Agca, Cheikh I. Seye

    Objectives: Extracellular nucleotide release at the site of arterial injury mediates the proliferation and migration of vascular smooth muscle cells. Our aim was to investigate the role of the P2Y2 nucleotide receptor (P2Y2R) in neointimal hyperplasia. Approach and Results: Vascular injury was induced by the implantation of a polyethylene cuff around the femoral artery in wild-type and P2Y2R-deficient mice (P2Y2R-/-). Electron microscopy was used to analyze monocyte and lymphocyte influx to the intima 36 h after injury. Compared to wild-type littermates, P2Y2R-/- mice exhibited a 3-fold decreased number of mononuclear leukocytes invading the intima (p < 0.05). Concomitantly, the migration of smooth muscle cells was decreased by more than 60% (p < 0.05), resulting in a sharp inhibition of intimal thickening formation in P2Y2R-/- mice (n = 15) 14 days after cuff placement. In vitro, loss of P2Y2R significantly impaired monocyte migration in response to nucleotide agonists. Furthermore, transgenic rats overexpressing the P2Y2R developed accelerated intimal lesions resulting in more than 95% luminal stenosis (p < 0.05, n = 10). Conclusions: Loss- and gain-of-function approaches established direct evidence for P2Y2R involvement in neointimal hyperplasia. Specific anti-P2Y2R therapies may be used against restenosis and bypass graft failure.


  • Open Access

    Deletion of P2Y 2 receptor reveals a role for lymphotoxin-α in fatty streak formation

    by Shaomin Qian, April Hoggatt, Yava L. Jones-Hall, Carl F. Ware, Paul Herring, Cheikh I. Seye